← All trials
NCT03369340
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 7, 2017
- Primary completion
- Feb 1, 2018
- Completion date
- May 2, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 18
- Arms / groups
- 6 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Philip MorrisLead sponsor
- Cross Research S.A.Overall official - principal investigator
- Philip MorrisStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.